Sitemap
Every section and article on longevitydocs™ News.
Pages
- Front page
- Latest
- Events
- Buzz in the chat
- About longevitydocs™ News
- Privacy
- Terms
- Accessibility
- Cookie settings
Research
- Aerobic exercise restores Klotho in aging cartilage
- Cardiolipin loss drives the muscle shift of aging
- Aging as the slow loss of cell identity
- Senolytics just moved liver fibrosis in a randomized trial
- Caloric restriction improves a composite aging-biomarker index
- Menopause leaves a molecular signature linked to brain aging
- Regular exercise rewires immune cells at the chromatin level
- REM sleep tracks lower risk across 83 diseases in 95,559 UK Biobank adults
- Ask about the parents. It beats the polygenic score.
- An AI-designed drug moved six aging clocks. In IPF patients. For 12 weeks.
- Aging-related disease is now the largest burden a newborn will face
- Verve-102: one-shot PCSK9 gene editing is not ready for patients
- Launching the First Longevity Clinical Trial Network
Clinical Practice
- Ferritin below 30 is the new line
- Where can I find a longevity doctor?
- Learning TRT: guidelines, commercial courses or an AI-built curriculum?
- How to Design a Patient Journey for a Longevity Clinic
- Is Your Clinic Longevity-Ready?
- Why More Doctors Are Moving Into Longevity Medicine
- Inside Shanghai and Seoul's top longevity clinics
- Should everyone with elevated Lp(a) take aspirin?
- What's a Longevity Doctor? 10 Traits
- Ferritin of 482 with normal iron studies: what next?
- Lp(a) in practice: what longevity physicians are actually doing
- HRT, coronary calcium and the stroke that split the room
- How to become a Longevity Doctor
- Longevity Tour: 50 Lessons from 5 Cities
- 10 core challenges longevity doctors are facing right now
- What is longevity medicine? From origins to futurism
- longevitydocs Concierge
Therapeutics
- The next wave of obesity drugs, from EASD
- Menopause hormone therapy, reframed as a healthy-aging intervention
- Tirzepatide earns its first outcomes label
- The Lp(a) drug moved the number, not the outcome
- Semaglutide, started late, extended life in mice
- Are NAD+ infusions safe?
- Testosterone pens: the option most physicians are not using
- GHK-Cu: topical beats injectable
- Stem cells: promise versus noise
- Teenagers are using peptides
- Perimenopausal weight gain is a diagnostic window, not a discipline failure
- HRT after breast cancer: the case for individualized risk
- Tirzepatide or semaglutide for alcohol cravings?
- GLP-1s and hair loss: nutrition, or something more?
- Are GLP-1s stealing joy?
- Cord blood banking: what physicians recommend to families
- Does spermidine promote cancer growth?
- Inside the longevitydocs Peptide Mastermind
- Peptides: meet the doctors speaking at the Mastermind
Diagnostics
- One in eight cancers worldwide starts with an infection
- Alzheimer’s blood tests are for symptomatic patients, not screening
- Which longevity data is worth acting on?
- Multi-cancer blood test performance in 35,900 adults (PATHFINDER 2)
- Aging Rate Indicators (ARI) measure pace, not accumulated age
- CAC 149, almost all in the LAD: what would you do next?
- Midjourney's body scanner: hype or hardware?
- Beta-blockers before a Cleerly CTA in bradycardic athletes
- Rapamycin and rising LDL: are we reading the wrong lipid?
- How do you measure senescent cell load in clinic?
- The Biomarker Gold Rush
- Longevity on a budget: the 50-cents-a-day promise
Technology
- Epic pauses product work after an AI finds MyChart security bugs
- Lab-grade breath testing goes self-serve
- Your ring now carries your chart
- Can your phone become a longevity clinic?
- A hormone panel from behind the ear, n=12
- ChatGPT is now reading your Epic chart
- The longevitydocs mobile app is live
- HRV: are doctors built different?
- AI scribes, HIPAA and decision support: what the chat is using
- Is HRV becoming a moral compass instead of a clinical metric?
- Ambient Longevity Already Exists.
- Welcome to Hippo: AI learning Assistant for longevity medicine
- The longevity clinic tech stack
- The AI Doctor Is Born
- The longevity EMR of the future
Business
- Viome buys Sōlaria Biō to move from testing to treating
- FDA approves AbbVie's Juvmo (tavapadon) for Parkinson's
- System raises $20M to own the peptide supply chain
- Bryan Johnson’s Immortals Concierge: from $75k to $1M
- Oura is going public with 3.6 million people's worth of data
- After the FDA crackdown: what cash-pay clinics are doing about compounded GLP-1s
- Mistakes to Avoid When Building a Longevity Practice
- The Longevity Tourism Boom
- Acquire Patients Better: The Physician-Patient Fit Checklist
- How to build a $1M longevity clinic
- Physicians are sharing lab contracts to negotiate with Quest and Labcorp
- The Longevity Clinic Gold Rush
- The Longevity Care Battle: Physician vs Digital Platform
- Smart investments for physicians
Policy
- FDA puts aging on its regulatory science agenda
- FDA puts a major GLP-1 compounder on notice
- $16.4 trillion: the economic case for prevention
- Deepfake doctors are selling pills
- Bill Targets Corporate Control of Doctors
- FDA opens the file on testosterone for menopause
- FDA advisory committee recommends six peptides for compounding
- Medspa madness: physicians are cleaning up after the wellness boom
Voices
- What People Get Wrong About Longevity Medicine
- 10 learnings from longevitydocs Cannes 2026
- Launching Jobs: refer, hire, partner
- Once upon a time in Cannes
- We are launching Events
- Rooms: the digital lounge for longevity doctors
- Should Doctors Build a Personal Brand?
- Launching longevitydocs 2.0
- From Barber To Longevity Doctor
- 2026 - The Longevity Medicine Manifesto
- 2025 Longevity Medicine Recap: What Accelerated, What Broke
- Introducing longevitydocs.network
- Doctor-Led Longevity: The New Standard of Care
- The rise of TikTok medicine
- Virtual Mastermind: live and recorded access is back
- Certification Cohort 3 is open
- longevitydocs Tables launch in the US
- Readers in 100+ countries: why this matters